Chemed Corp (CHE) stock analysis

CHE · Chemed Corp

Latest recorded price: USD 550.05

Model-estimated fair value: USD 362.73. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Care Facilities

At $550.05, CHE trades 51.6% above the model's base-case value of $362.73. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $287.84 in the conservative case and $446.55 in the optimistic case, with a valuation confidence score of 80/100. About 77% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 5.8%, free cash flow margin 12.9%, ROIC 22.9%. The model flags 1 risk signal for this company.

Similar companies in Healthcare